Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients ...

Foralumab is the first fully human anti-CD3 monoclonal antibody administered via the intranasal route. This novel, non-systemic approach is designed to engage regulatory T cells, promoting immune ...

Neurology experts from UCSF Health presented new clinical research findings and cutting-edge treatment strategies and received distinguished awards recognition at the American Academy of Neurology’s ...

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

Sanofi and Regeneron's fully human monoclonal antibody Dupixent (dupilumab) has gained approval from the US Food and Drug ...

Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

Membrane chromatography offers significant advantages over traditional column chromatography, including higher throughput, reduced processing times and enhanced scalability, making it an interesting ...

MONDAY, April 14, 2025 (HealthDay News) -- The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs .